Showing results (1-10 of 585) with videos related to
Sort By:
Pageof 59
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs as drug targetsPatrick M Sexton, David R Poyner, John Simms, et al.Molecular Pharmacology|February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexesDebbie L Hay, George Christopoulos, Arthur Christopoulos, et al.Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.Pharmacology & Therapeutics|August 23, 2005
GPCR modulation by RAMPsDebbie L Hay, David R Poyner, Patrick M SextonMolecular Pharmacology|September 9, 2006
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1Debbie L Hay, George Christopoulos, Arthur Christopoulos, et al.Biophysical Journal|April 25, 2006
Characterization of the structure of RAMP1 by mutagenesis and molecular modelingJohn Simms, Debbie L Hay, Mark Wheatley, et al.Handbook of Experimental Pharmacology|January 7, 2012
Structure-function studies of muscarinic acetylcholine receptorsKatie Leach, John Simms, Patrick M Sexton, et al.Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs and CGRP receptorsJames Barwell, Denise Wootten, John Simms, et al.Cell Discovery|July 28, 2016
Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.Pageof 59